Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

ClinicalTrials.gov ID: NCT01121484

Public ClinicalTrials.gov record NCT01121484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A multicenter, 10-week study to evaluate the efficacy and safety of 50 mg of desvenlafaxine succinate sustained-release formulation (DVS SR) versus placebo in the treatment of peri- and postmenopausal women with major depressive disorder

Study identification

NCT ID
NCT01121484
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
439 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
May 31, 2011
Completion
May 31, 2011
Last update posted
Apr 3, 2012

2010 – 2011

United States locations

U.S. sites
44
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226
Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Little Rock Arkansas 72223
Pacific Clinical Research Medical Group Arcadia California 91007-3462
Southwestern Research, Inc. Beverly Hills California 90210
Catalina Research Institute LLC Chino California 91710
Pacific Clinical Research Medical Group Orange California 92868
Pacific Clinical Research Medical Group Upland California 91786
Western Affiliated Research Institute Denver Colorado 80209
Radiant Research, Inc. Denver Colorado 80239
Connecticut Clinical Research Cromwell Connecticut 06416
Comprehensive NeuroScience, Inc. St. Petersburg Florida 33716
Stedman Clinical Trials, LLC Tampa Florida 33613
Janus Center for Psychiatric Research West Palm Beach Florida 33407
Emory University Department of Psychiatry and Behavioral Sciences Atlanta Georgia 30306
Atlanta Center for Medical Research Atlanta Georgia 30308
Northwest Behavioral Research Center Roswell Georgia 30076
Carman Research Smyrna Georgia 30080
Capstone Clinical Research Libertyville Illinois 60048
Deaconess Clinic Gateway Health Center Research Institute Newburgh Indiana 47630
Via Christi Research Witchita Kansas 67214
Westside Family Medical Center, P.C. Kalamazoo Michigan 49009
Radiant Research, Inc. Las Vegas Nevada 89146
Center For Emotional Fitness Cherry Hill New Jersey 08002
Robert Wood Johnson Medical School Piscataway New Jersey 08854
Social Psychiatry Research Institute Brooklyn New York 11235
Medical & Behavioral Health Research PC New York New York 10023
Metrolina Medical Research Charlotte North Carolina 28209
Horizon Medical Services, PC Bismarck North Dakota 58501
Legacy Pharma Research Bismarck North Dakota 58501
North Coast Clinical Trials, Inc. Beechwood Ohio 44122
Midwest Clinical Research Center Dayton Ohio 45417
Summit Research Network (Oregon), Inc. Portland Oregon 97210
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Omega Medical Research Warwick Rhode Island 02886
Carolina Clinical Research Services, LLC Columbia South Carolina 29201
Holston Medical Group Bristol Tennessee 37620
Holston Medical Group Kingsport Tennessee 37660
Bayou City Research, Ltd. Houston Texas 77007
Radiant Research, Inc. San Antonio Texas 78229
University of Virginia Health System Center for Psychiatric Clinical Research Charlottesville Virginia 22903
Nelson Clinic Richmond Virginia 23298
Northwest Clinical Research Center Bellevue Washington 98007
Summit Research Network (Seattle) LLC Seattle Washington 98104
Independent Psychiatric Consultants, SC dba IPC Research Waukesha Wisconsin 53188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01121484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01121484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →